Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
06.06. | TOWN HEALTH (03886): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | - | HKEx | ||
06.06. | TOWN HEALTH (03886): POLL RESULTS OF THE ANNUAL GENERAL MEETING AND CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE | - | HKEx | ||
29.04. | TOWN HEALTH (03886): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
TOWN HEALTH Aktie jetzt für 0€ handeln | |||||
29.04. | TOWN HEALTH (03886): NOTIFICATION LETTER AND CHANGE REQUEST FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
29.04. | TOWN HEALTH (03886): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED) | - | HKEx | ||
29.04. | TOWN HEALTH (03886): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
29.04. | TOWN HEALTH (03886): FORM OF PROXY | 1 | HKEx | ||
29.04. | TOWN HEALTH (03886): (1) RE-ELECTION OF RETIRING DIRECTORS; (2) GRANT OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES; (3) PROPOSED FINAL ... | - | HKEx | ||
29.04. | TOWN HEALTH (03886): 2024 ANNUAL REPORT | - | HKEx | ||
28.03. | TOWN HEALTH (03886): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 | 2 | HKEx | ||
28.03. | TOWN HEALTH (03886): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 | - | HKEx | ||
18.03. | TOWN HEALTH (03886): DATE OF BOARD MEETING | 2 | HKEx | ||
24.02. | TOWN HEALTH (03886): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 1 | HKEx | ||
24.02. | TOWN HEALTH (03886): RESIGNATION AND APPOINTMENT OF EXECUTIVE DIRECTOR | 1 | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 0,347 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ in Leptomeningeal Metastases | Primary objective to determine optimal dosing schedule for a registrational trial Trial builds on recommended Phase 2 dose determined in completed Phase 1 trial Trial benefits from $17.6M award... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,490 | -1,21 % | Neue 5,68% Aktienanleihe auf Siemens Healthineers | Düsseldorf (www.anleihencheck.de) - Die HSBC Trinkaus & Burkhardt AG, Düsseldorf, bietet ab dem 24. Juni 2025 eine neue Aktienanleihe (ISIN DE000HT69A65/ WKN HT69A6) auf die Aktie der Siemens Healthineers... ► Artikel lesen | |
FRESENIUS | 42,770 | +0,16 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
NUTEX HEALTH | 124,49 | 0,00 % | Nutex Health added to Russell 3000 and Russell Microcap Index | ||
FRESENIUS MEDICAL CARE | 48,680 | +0,52 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
GERRESHEIMER | 46,860 | -2,13 % | Gerresheimer-Aktie: Bleibt die Übernahmefantasie? | Die Gerresheimer-Aktie musste zuletzt heftige Kursverluste hinnehmen. Am Donnerstag verbessert sie sich leicht und steht aktuell bei 47,30 €. Die Ursache für die hohen Kursschwankungen waren Nachrichten... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 23,010 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 23,590 | 0,00 % | TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy | ||
NEUROPACE | 11,140 | 0,00 % | NeuroPace, Inc.: NeuroPace Announces Strategic CFO Transition | Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory... ► Artikel lesen | |
CARL ZEISS MEDITEC | 55,90 | 0,00 % | Carl Zeiss Meditec AG: Chirurgische Präzision, strategische Genauigkeit; mwb research stuft auf KAUFEN | Carl Zeiss Meditec (CZM) bleibt ein weltweit führender Anbieter in der Augenheilkunde und Mikrochirurgie, gestützt durch strukturelle Wachstumstreiber wie demografischen Wandel und die Zunahme von Sehstörungen.... ► Artikel lesen | |
LIFEMD | 13,620 | 0,00 % | Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? | ||
GENEDX | 92,23 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts | ||
ALIGNMENT HEALTHCARE | 13,995 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
PROGYNY | 21,995 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
PROCEPT BIOROBOTICS | 57,65 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |